Temasek backs Chinese biotech firm Innovent's $150m Series E

Temasek backs Chinese biotech firm Innovent's $150m Series E

Photo by Martin Lopez from Pexels

Singapore’s Temasek Holdings joined a $150-million Series E funding round in Chinese biotech firm Innovent Biologics, Inc., according to a company announcement on Thursday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter